Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adri Steenhoek

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|December 3, 2014
Health economic evaluations in reimbursement decision making in the Netherlands: time to take it seriously?Margreet Franken, Marc Koopmanschap, Adri Steenhoek
Orphanet Journal of Rare Diseases|October 12, 2014
Orphan drugs expenditure in the Netherlands in the period 2006-2012Tim A Kanters, Adri Steenhoek, Leona Hakkaart
Nederlands Tijdschrift Voor Geneeskunde|May 12, 2020
[40 years of medicines policy in the Netherlands: from financial constraints to medicines shortages?]Adri Steenhoek, Marc Koopmanschap, J F Piepenbrink
Expert Review of Pharmacoeconomics & Outcomes Research|June 16, 2010
The economics of improved cancer survival rates: better outcomes, higher costsCarin A Uyl-de Groot, Saskia de Groot, Adri Steenhoek
Health Policy (Amsterdam, Netherlands)|May 1, 2013
Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over timeFrank G Sandmann, Margreet G Franken, Adri Steenhoek, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 26, 2011
[New drugs: money-back guarantee?]Adri Steenhoek, Marc A Koopmanschap, Margreet G Franken, et al.
Value in Health Regional Issues|April 29, 2018
The Drug Reimbursement Decision-Making System in IranAmir Ansaripour, Carin A Uyl-de Groot, Adri Steenhoek, et al.
European Journal of Cancer (Oxford, England : 1990)|September 19, 2006
Inequalities in oncology care: Economic consequences of high cost drugsMaartje G H Niezen, Elly A Stolk, Adri Steenhoek, et al.
Health Care Management Science|March 17, 2015
Productivity and quality of Dutch hospitals during system reformMartin van Ineveld, Jeroen van Oostrum, Rob Vermeulen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2012
Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The NetherlandsMargreet G Franken, Chantal W M van Gils, Jennifer G Gaultney, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|December 3, 2014
Health economic evaluations in reimbursement decision making in the Netherlands: time to take it seriously?Margreet Franken, Marc Koopmanschap, Adri Steenhoek
Orphanet Journal of Rare Diseases|October 12, 2014
Orphan drugs expenditure in the Netherlands in the period 2006-2012Tim A Kanters, Adri Steenhoek, Leona Hakkaart
Nederlands Tijdschrift Voor Geneeskunde|May 12, 2020
[40 years of medicines policy in the Netherlands: from financial constraints to medicines shortages?]Adri Steenhoek, Marc Koopmanschap, J F Piepenbrink
Expert Review of Pharmacoeconomics & Outcomes Research|June 16, 2010
The economics of improved cancer survival rates: better outcomes, higher costsCarin A Uyl-de Groot, Saskia de Groot, Adri Steenhoek
Health Policy (Amsterdam, Netherlands)|May 1, 2013
Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over timeFrank G Sandmann, Margreet G Franken, Adri Steenhoek, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 26, 2011
[New drugs: money-back guarantee?]Adri Steenhoek, Marc A Koopmanschap, Margreet G Franken, et al.
Value in Health Regional Issues|April 29, 2018
The Drug Reimbursement Decision-Making System in IranAmir Ansaripour, Carin A Uyl-de Groot, Adri Steenhoek, et al.
European Journal of Cancer (Oxford, England : 1990)|September 19, 2006
Inequalities in oncology care: Economic consequences of high cost drugsMaartje G H Niezen, Elly A Stolk, Adri Steenhoek, et al.
Health Care Management Science|March 17, 2015
Productivity and quality of Dutch hospitals during system reformMartin van Ineveld, Jeroen van Oostrum, Rob Vermeulen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2012
Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The NetherlandsMargreet G Franken, Chantal W M van Gils, Jennifer G Gaultney, et al.
Pageof 1